Symbols / PETS $2.32 +0.87% PetMed Express, Inc.
PETS Chart
About
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Fundamentals
Scroll to Statements| Market Cap | 49.65M | Enterprise Value | 22.91M | Income | -64.87M | Sales | 186.96M | Book/sh | 1.53 | Cash/sh | 1.26 |
| Dividend Yield | — | Payout | 0.00% | Employees | 173 | IPO | — | P/E | — | Forward P/E | -77.33 |
| PEG | 2.32 | P/S | 0.27 | P/B | 1.51 | P/C | — | EV/EBITDA | -0.80 | EV/Sales | 0.12 |
| Quick Ratio | 0.52 | Current Ratio | 0.89 | Debt/Eq | 1.99 | LT Debt/Eq | — | EPS (ttm) | -3.11 | EPS next Y | -0.03 |
| EPS Growth | — | Revenue Growth | -21.70% | Earnings | 2026-06-10 | ROA | -20.32% | ROE | -100.61% | ROIC | — |
| Gross Margin | 27.53% | Oper. Margin | -25.73% | Profit Margin | -34.70% | Shs Outstand | 21.40M | Shs Float | 13.89M | Short Float | 4.59% |
| Short Ratio | 8.28 | Short Interest | — | 52W High | 4.32 | 52W Low | 1.57 | Beta | 0.78 | Avg Volume | 112.66K |
| Volume | 107.26K | Target Price | $2.75 | Recom | None | Prev Close | $2.30 | Price | $2.32 | Change | 0.87% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-04-17 | main | Morgan Stanley | Underweight → Underweight | $3 |
| 2024-08-07 | down | Lake Street | Buy → Hold | $4 |
| 2024-06-12 | main | Lake Street | Buy → Buy | $7 |
| 2024-06-12 | main | Morgan Stanley | Underweight → Underweight | $4 |
| 2023-11-16 | main | Morgan Stanley | Underweight → Underweight | $7 |
| 2023-10-31 | main | Morgan Stanley | Underweight → Underweight | $7 |
| 2023-10-19 | main | Morgan Stanley | Underweight → Underweight | $10 |
| 2023-07-27 | reit | Morgan Stanley | Underweight → Underweight | $17 |
| 2023-05-25 | init | Lake Street | — → Buy | $20 |
| 2023-03-23 | main | Morgan Stanley | — → Underweight | $17 |
| 2022-11-08 | main | Morgan Stanley | — → Underweight | $18 |
| 2022-07-26 | main | Morgan Stanley | — → Underweight | $19 |
| 2022-05-10 | main | Morgan Stanley | — → Underweight | $20 |
| 2022-01-25 | main | Morgan Stanley | — → Underweight | $21 |
| 2022-01-20 | up | Sidoti & Co. | Neutral → Buy | $32 |
| 2021-11-18 | init | Morgan Stanley | — → Underweight | $25 |
| 2021-10-01 | init | Jefferies | — → Hold | $28 |
| 2021-06-03 | down | Sidoti & Co. | Buy → Neutral | $39 |
| 2021-03-05 | up | Sidoti & Co. | Neutral → Buy | — |
| 2020-08-19 | up | Sidoti & Co. | Neutral → Buy | $41 |
- Rural King shoppers gain pet pharmacy access through PetMeds - Stock Titan Wed, 22 Apr 2026 20
- PetMed Express (PETS) Stock: Near Breakout? (Buying Pressure) 2026-04-20 - Fast Rising Picks - Cổng thông tin điện tử tỉnh Lào Cai Mon, 20 Apr 2026 23
- Stock Pitch: Is Pets at Home poised for a Tesco-style turnaround? - Stockopedia Wed, 22 Apr 2026 09
- $PETS stock is up 9% today. Here's what we see in our data. - Quiver Quantitative Wed, 22 Oct 2025 07
- The Humanization of Pets Makes This Undervalued Stock Even More Attractive - The Motley Fool Sat, 28 Mar 2026 07
- Weak Financial Prospects Seem To Be Dragging Down Pets at Home Group Plc (LON:PETS) Stock - Yahoo Finance Wed, 05 Nov 2025 08
- Is PetMed Express (PETS) Stock Safe to Buy Now | Price at $2.31, Up 0.74% - Most Watched Stocks - Cổng thông tin điện tử Tỉnh Sơn La Mon, 06 Apr 2026 07
- PetMed Express stock soars on $4 per share buyout offer - Investing.com hu, 11 Dec 2025 08
- PETS Stock Soars as Cardone Ventures Proposes $89M Acquisition - GuruFocus ue, 16 Dec 2025 08
- 10 Pet Stocks Benefitting From the World’s Growing Love for Pets - TIKR.com hu, 02 Oct 2025 07
- Petmed Express Stock Jumps On Buyout Offer From Largest Shareholder SilverCape Investments - Stocktwits hu, 11 Dec 2025 08
- Cyber pets, blind dates, and stock trading: How Chinese users are jumping on the OpenClaw craze - Business Insider Sun, 15 Mar 2026 07
- Billionaire-backed firm makes cash offer for PetMed Express - Stock Titan ue, 16 Dec 2025 08
- $PETS stock is up 38% today. Here's what we see in our data. | PETS Stock News - Quiver Quantitative hu, 11 Dec 2025 08
- PetMed Express (PETS) Shares Surge on Takeover Proposal - GuruFocus Sat, 13 Dec 2025 08
Insider Transactions
Financials
| Line Item | Trend | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Revenue |
|
274.10
+10.71%
|
247.57
-9.08%
|
272.28
|
| Operating Revenue |
|
274.10
+10.71%
|
247.57
-9.08%
|
272.28
|
| Cost Of Revenue |
|
189.33
+10.67%
|
171.07
-12.43%
|
195.34
|
| Reconciled Cost Of Revenue |
|
189.33
+10.67%
|
171.07
-12.43%
|
195.34
|
| Gross Profit |
|
84.77
+10.81%
|
76.50
-0.57%
|
76.94
|
| Operating Expense |
|
92.93
+31.91%
|
70.45
+33.81%
|
52.65
|
| Selling General And Administration |
|
85.87
+28.35%
|
66.90
+34.04%
|
49.91
|
| Selling And Marketing Expense |
|
30.63
+21.59%
|
25.19
+34.00%
|
18.80
|
| General And Administrative Expense |
|
55.25
+32.44%
|
41.71
+34.07%
|
31.11
|
| Other Gand A |
|
55.25
+32.44%
|
41.71
+34.07%
|
31.11
|
| Total Expenses |
|
282.26
+16.87%
|
241.52
-2.61%
|
247.99
|
| Operating Income |
|
-8.16
-234.89%
|
6.05
-75.09%
|
24.29
|
| Total Operating Income As Reported |
|
-8.16
-234.89%
|
6.05
-75.09%
|
24.29
|
| EBITDA |
|
-1.11
-111.52%
|
9.60
-64.49%
|
27.03
|
| Normalized EBITDA |
|
-1.11
-111.52%
|
9.60
-64.49%
|
27.03
|
| Reconciled Depreciation |
|
7.06
+98.98%
|
3.55
+29.51%
|
2.74
|
| EBIT |
|
-8.16
-234.89%
|
6.05
-75.09%
|
24.29
|
| Net Income |
|
-7.46
-245.21%
|
5.14
-72.54%
|
18.72
|
| Pretax Income |
|
-6.27
-184.26%
|
7.45
-69.22%
|
24.18
|
| Net Non Operating Interest Income Expense |
|
0.51
+13.56%
|
0.45
+139.79%
|
-1.13
|
| Net Interest Income |
|
—
|
0.45
+139.79%
|
-1.13
|
| Interest Income Non Operating |
|
—
|
0.45
+34.33%
|
0.34
|
| Interest Income |
|
—
|
0.45
+34.33%
|
0.34
|
| Other Income Expense |
|
1.38
+45.97%
|
0.94
-7.99%
|
1.03
|
| Other Non Operating Income Expenses |
|
1.38
+45.97%
|
0.94
-7.99%
|
1.03
|
| Tax Provision |
|
1.19
-48.33%
|
2.31
-57.85%
|
5.47
|
| Tax Rate For Calcs |
|
0.00
-32.26%
|
0.00
+36.56%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-7.46
-245.21%
|
5.14
-72.54%
|
18.72
|
| Net Income From Continuing Operation Net Minority Interest |
|
-7.46
-245.21%
|
5.14
-72.54%
|
18.72
|
| Net Income From Continuing And Discontinued Operation |
|
-7.46
-245.21%
|
5.14
-72.54%
|
18.72
|
| Net Income Continuous Operations |
|
-7.46
-245.21%
|
5.14
-72.54%
|
18.72
|
| Normalized Income |
|
-7.46
-245.21%
|
5.14
-72.54%
|
18.72
|
| Net Income Common Stockholders |
|
-7.46
-245.21%
|
5.14
-72.54%
|
18.72
|
| Diluted EPS |
|
-0.37
-3800.00%
|
0.01
-99.04%
|
1.04
|
| Basic EPS |
|
-0.37
-3800.00%
|
0.01
-99.05%
|
1.05
|
| Basic Average Shares |
|
20.40
+0.60%
|
20.27
+0.49%
|
20.18
|
| Diluted Average Shares |
|
20.40
+0.28%
|
20.34
-0.09%
|
20.36
|
| Diluted NI Availto Com Stockholders |
|
-7.46
-245.21%
|
5.14
-72.54%
|
18.72
|
| Depreciation Amortization Depletion Income Statement |
|
7.06
+98.98%
|
3.55
+29.51%
|
2.74
|
| Depreciation And Amortization In Income Statement |
|
7.06
+98.98%
|
3.55
+29.51%
|
2.74
|
| Depreciation Income Statement |
|
—
|
3.55
+29.51%
|
2.74
|
| Total Other Finance Cost |
|
-0.51
-13.56%
|
-0.45
-139.79%
|
1.13
|
| Line Item | Trend | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Assets |
|
169.88
+1.44%
|
167.48
-6.80%
|
179.70
|
| Current Assets |
|
93.65
-28.20%
|
130.43
-13.62%
|
151.00
|
| Cash Cash Equivalents And Short Term Investments |
|
55.30
-46.87%
|
104.09
-6.30%
|
111.08
|
| Cash And Cash Equivalents |
|
55.30
-46.87%
|
104.09
-6.30%
|
111.08
|
| Receivables |
|
3.28
+88.68%
|
1.74
-9.04%
|
1.91
|
| Accounts Receivable |
|
3.28
+88.68%
|
1.74
-9.04%
|
1.91
|
| Gross Accounts Receivable |
|
3.56
+100.34%
|
1.77
-9.07%
|
1.95
|
| Allowance For Doubtful Accounts Receivable |
|
-0.27
-680.00%
|
-0.04
+10.26%
|
-0.04
|
| Inventory |
|
28.56
+50.11%
|
19.02
-41.39%
|
32.45
|
| Finished Goods |
|
—
|
19.02
-41.39%
|
32.45
|
| Prepaid Assets |
|
0.19
-78.22%
|
0.86
+26.73%
|
0.68
|
| Other Current Assets |
|
6.33
+34.03%
|
4.72
-3.02%
|
4.87
|
| Total Non Current Assets |
|
76.24
+105.78%
|
37.05
+29.07%
|
28.70
|
| Net PPE |
|
28.09
+7.30%
|
26.18
+7.01%
|
24.46
|
| Gross PPE |
|
48.22
+16.44%
|
41.41
+14.55%
|
36.15
|
| Accumulated Depreciation |
|
-20.13
-32.15%
|
-15.23
-30.35%
|
-11.69
|
| Properties |
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
3.70
+0.00%
|
3.70
+0.00%
|
3.70
|
| Buildings And Improvements |
|
19.51
+3.15%
|
18.91
+6.07%
|
17.83
|
| Machinery Furniture Equipment |
|
23.57
+25.43%
|
18.80
+28.57%
|
14.62
|
| Other Properties |
|
1.43
|
—
|
—
|
| Goodwill And Other Intangible Assets |
|
37.86
+4302.44%
|
0.86
+0.00%
|
0.86
|
| Goodwill |
|
26.66
|
0.00
|
—
|
| Other Intangible Assets |
|
11.20
+1202.67%
|
0.86
|
—
|
| Investments And Advances |
|
5.30
+6.00%
|
5.00
|
—
|
| Other Investments |
|
5.30
+6.00%
|
5.00
|
—
|
| Non Current Deferred Assets |
|
4.99
-0.46%
|
5.01
+48.24%
|
3.38
|
| Non Current Deferred Taxes Assets |
|
4.99
-0.46%
|
5.01
+48.24%
|
3.38
|
| Total Liabilities Net Minority Interest |
|
73.15
+27.20%
|
57.51
+2.25%
|
56.25
|
| Current Liabilities |
|
72.16
+25.47%
|
57.51
+2.25%
|
56.25
|
| Payables And Accrued Expenses |
|
69.10
+20.14%
|
57.51
+2.25%
|
56.25
|
| Payables |
|
63.64
+20.76%
|
52.70
+0.72%
|
52.33
|
| Accounts Payable |
|
37.02
+46.87%
|
25.21
-8.33%
|
27.50
|
| Dividends Payable |
|
1.47
+16.16%
|
1.26
+126.16%
|
0.56
|
| Current Accrued Expenses |
|
5.45
+13.32%
|
4.81
+22.67%
|
3.92
|
| Total Tax Payable |
|
25.15
-4.11%
|
26.23
+8.09%
|
24.27
|
| Current Debt And Capital Lease Obligation |
|
0.46
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.46
|
0.00
|
—
|
| Current Deferred Liabilities |
|
2.60
|
0.00
|
—
|
| Current Deferred Revenue |
|
2.60
|
0.00
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.99
|
0.00
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.99
|
0.00
|
—
|
| Long Term Capital Lease Obligation |
|
0.99
|
0.00
|
—
|
| Non Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
0.94
|
| Non Current Deferred Taxes Liabilities |
|
—
|
0.00
-100.00%
|
0.94
|
| Other Non Current Liabilities |
|
—
|
3.83
|
—
|
| Stockholders Equity |
|
96.73
-12.04%
|
109.97
-10.92%
|
123.45
|
| Common Stock Equity |
|
96.72
-12.04%
|
109.96
-10.92%
|
123.44
|
| Capital Stock |
|
0.03
+0.00%
|
0.03
+0.00%
|
0.03
|
| Common Stock |
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
|
| Preferred Stock |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
|
| Share Issued |
|
21.15
+0.31%
|
21.08
+0.50%
|
20.98
|
| Ordinary Shares Number |
|
21.15
+0.31%
|
21.08
+0.50%
|
20.98
|
| Additional Paid In Capital |
|
25.15
+37.58%
|
18.28
+56.75%
|
11.66
|
| Retained Earnings |
|
71.56
-21.93%
|
91.66
-17.99%
|
111.76
|
| Total Equity Gross Minority Interest |
|
96.73
-12.04%
|
109.97
-10.92%
|
123.45
|
| Total Capitalization |
|
96.73
-12.04%
|
109.97
-10.92%
|
123.45
|
| Working Capital |
|
21.49
-70.53%
|
72.92
-23.04%
|
94.75
|
| Invested Capital |
|
96.72
-12.04%
|
109.96
-10.92%
|
123.44
|
| Total Debt |
|
1.45
|
0.00
|
—
|
| Capital Lease Obligations |
|
1.45
|
0.00
|
—
|
| Net Tangible Assets |
|
58.87
-46.04%
|
109.11
-11.00%
|
122.59
|
| Tangible Book Value |
|
58.86
-46.05%
|
109.10
-11.00%
|
122.58
|
| Other Inventories |
|
28.56
+50.11%
|
19.02
-41.39%
|
32.45
|
| Preferred Shares Number |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Preferred Stock Equity |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
|
| Line Item | Trend | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
4.32
-84.47%
|
27.80
+50.30%
|
18.50
|
| Cash Flow From Continuing Operating Activities |
|
4.32
-84.47%
|
27.80
+50.30%
|
18.50
|
| Net Income From Continuing Operations |
|
-7.46
-245.21%
|
5.14
-72.54%
|
18.72
|
| Depreciation Amortization Depletion |
|
7.06
+98.98%
|
3.55
+29.51%
|
2.74
|
| Depreciation |
|
5.20
+48.57%
|
3.50
+29.63%
|
2.70
|
| Amortization Cash Flow |
|
2.00
|
0.00
|
0.00
|
| Depreciation And Amortization |
|
7.06
+98.98%
|
3.55
+29.51%
|
2.74
|
| Amortization Of Intangibles |
|
2.00
|
0.00
|
0.00
|
| Stock Based Compensation |
|
6.87
+3.81%
|
6.62
+45.46%
|
4.55
|
| Asset Impairment Charge |
|
0.32
+51.40%
|
0.21
+29.70%
|
0.17
|
| Deferred Tax |
|
0.29
+117.91%
|
-1.63
-92.67%
|
-0.85
|
| Deferred Income Tax |
|
0.29
+117.91%
|
-1.63
-92.67%
|
-0.85
|
| Change In Working Capital |
|
-2.76
-119.83%
|
13.92
+303.93%
|
-6.82
|
| Change In Receivables |
|
-1.74
-4148.78%
|
-0.04
-108.06%
|
0.51
|
| Changes In Account Receivables |
|
-1.74
-4148.78%
|
-0.04
-108.06%
|
0.51
|
| Change In Inventory |
|
-6.42
-147.77%
|
13.43
+583.56%
|
1.97
|
| Change In Prepaid Assets |
|
0.49
+1500.00%
|
-0.04
+58.82%
|
-0.09
|
| Change In Payables And Accrued Expense |
|
5.28
+842.32%
|
0.56
+106.08%
|
-9.21
|
| Change In Accrued Expense |
|
0.28
-69.20%
|
0.90
+1063.44%
|
-0.09
|
| Change In Payable |
|
5.00
+1588.39%
|
-0.34
+96.32%
|
-9.12
|
| Change In Account Payable |
|
6.10
+366.23%
|
-2.29
+80.98%
|
-12.05
|
| Change In Other Working Capital |
|
-0.39
|
—
|
—
|
| Change In Other Current Assets |
|
0.79
|
0.00
|
0.00
|
| Change In Other Current Liabilities |
|
-0.77
|
0.00
|
0.00
|
| Investing Cash Flow |
|
-40.67
-296.39%
|
-10.26
-485.62%
|
-1.75
|
| Cash Flow From Continuing Investing Activities |
|
-40.67
-296.39%
|
-10.26
-485.62%
|
-1.75
|
| Net PPE Purchase And Sale |
|
-4.51
+14.24%
|
-5.26
-200.23%
|
-1.75
|
| Purchase Of PPE |
|
-4.51
+14.24%
|
-5.26
-200.23%
|
-1.75
|
| Capital Expenditure |
|
-4.51
+14.24%
|
-5.26
-200.23%
|
-1.75
|
| Net Business Purchase And Sale |
|
-36.16
-623.18%
|
-5.00
|
0.00
|
| Purchase Of Business |
|
-36.16
-623.18%
|
-5.00
|
0.00
|
| Financing Cash Flow |
|
-12.44
+49.31%
|
-24.54
-0.63%
|
-24.38
|
| Cash Flow From Continuing Financing Activities |
|
-12.44
+49.31%
|
-24.54
-0.63%
|
-24.38
|
| Net Common Stock Issuance |
|
—
|
—
|
0.00
|
| Common Stock Payments |
|
—
|
—
|
0.00
|
| Common Stock Dividend Paid |
|
—
|
-24.54
-0.63%
|
-24.38
|
| Cash Dividends Paid |
|
-12.44
+49.31%
|
-24.54
-0.63%
|
-24.38
|
| Repurchase Of Capital Stock |
|
—
|
—
|
0.00
|
| Changes In Cash |
|
-48.79
-597.60%
|
-6.99
+8.43%
|
-7.64
|
| Beginning Cash Position |
|
104.09
-6.30%
|
111.08
-6.43%
|
118.72
|
| End Cash Position |
|
55.30
-46.87%
|
104.09
-6.30%
|
111.08
|
| Free Cash Flow |
|
-0.19
-100.86%
|
22.54
+34.62%
|
16.75
|
| Income Tax Paid Supplemental Data |
|
0.13
-96.99%
|
4.31
-29.14%
|
6.08
|
| Change In Income Tax Payable |
|
-1.10
-156.29%
|
1.96
-33.20%
|
2.93
|
| Change In Tax Payable |
|
-1.10
-156.29%
|
1.96
-33.20%
|
2.93
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-Q2026-02-05 View
- 42026-01-23 View
- 8-K2026-01-23 View
- 10-Q2025-12-19 View
- 10-Q2025-12-19 View
- 8-K2025-12-09 View
- 8-K2025-11-26 View
- 42025-11-14 View
- 8-K2025-11-13 View
- 42025-11-03 View
- 42025-11-03 View
- 42025-11-03 View
- 42025-11-03 View
- 42025-11-03 View
- 8-K2025-10-21 View
- 8-K2025-10-14 View
- 10-K2025-10-14 View
- 8-K2025-10-07 View
- 8-K2025-09-12 View
- 42025-09-11 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|